Back

The hemodynamic and cardiometabolic effects of butyrate infusion in ischemic cardiogenic shock

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure: new insights and treatments Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Lasse Juul Christensen

Aarhus N (Denmark)

6 More presentations in this session

Presentation thumbnail
The experience of more than three hundred levosimendan administrations: what we have learned
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Albuminuria and acute heart failure. Prognostic implications and short-term mortality.
Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes in acute heart failure patients stratified by left ventricular ejection fraction
Doctor A. Feuerstein (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Assessment of biomarkers for iron deficiency following acute decompensated heart failure and its outcomes: a retrospective real-world clinical cohort study
Doctor J. Johansson (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Temporary right heart catheterization in a stable state improves prognosis by optimizing guideline-directed medical therapy in patients with acute heart failure
Doctor R. Matsukawa (Iizuka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure: new insights and treatments

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Divergent hemometabolic dynamics: understanding the differences between acute myocardial infarction and heart failure related cardiogenic shock.
thumbnail
Congress Presentation
Ketone body supplementation attenuates myocardial fibrosis in an experimental model of sepsis
thumbnail
Congress Presentation
Improved cardiac function by medium-chain triacylglycerol intake links to increased fat and ketone body availability

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources